Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
nHFV may leads to lower chronic lung disease compared with nIPPV used (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes chronic lung disease compared with HFNC (very low certainty).
1 finding from 1 review
Chronic lung disease · ventilated preterm infants with planned extubation
nHFV may leads to lower chronic lung disease compared with nCPAP (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
It is very uncertain whether nHFV changes chronic lung disease compared with invasive respiratory therapy (very low certainty).
1 finding from 1 review
Chronic lung disease · ventilated preterm infants with planned extubation
nHFV showed no clear difference in chronic lung disease compared with nIPPV (moderate certainty).
1 finding from 1 review
Chronic lung disease · ventilated preterm infants with failure of initial non‐invasive respiratory support
nHFV showed no clear difference in chronic lung disease compared with nIPPV following failure of initial non‐invasive respiratory support (low certainty).
1 finding from 1 review
Chronic lung disease · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in chronic lung disease compared with nCPAP used (low certainty).
1 finding from 1 review
Chronic lung disease · neonates with sepsis
It is very uncertain whether pentoxifylline with antibiotics (any dose or duration) changes chronic lung disease compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Chronic lung disease · )
Nasal intermittent positive pressure ventilation (NIPPV) may leads to lower chronic lung disease compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Chronic lung disease · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
Chronic lung disease · preterm or low birth weight infants
It is very uncertain whether late (seven days or more following birth) higher changes chronic lung disease compared with lower sodium intake (very low certainty).
1 finding from 1 review
Chronic lung disease · preterm or low birth weight infants
1 finding from 1 review
Chronic lung disease · preterm or low birth weight infants
1 finding from 1 review
Chronic lung disease · prevention of sepsis and necrotizing enterocolitis in preterm infants
It is very uncertain whether lactoferrin supplementation with enteral feeds in combination with… changes chronic lung disease compared with placebo (very low certainty).
1 finding from 1 review
Chronic lung disease · preventing respiratory failure in preterm infants
1 finding from 1 review
Chronic lung disease · preterm infants
Very early treatment showed no clear difference in chronic lung disease compared with expectant management (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants
Early treatment showed no clear difference in chronic lung disease compared with expectant management (moderate certainty).
1 finding from 1 review
Death or chronic lung disease · newborn (term* and preterm) infants with respiratory distress for initial respiratory support
nHFV showed no clear difference in death or chronic lung disease compared with nCPAP used (low certainty).
1 finding from 1 review
Death or chronic lung disease · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review
Death or chronic lung disease · preterm infants with respiratory distress for initial respiratory support
1 finding from 1 review